Member Info for ratcliffewriter

Interesting to see this link posted by Raypointer yesterday - https://news.sky.com/story/coronavirus-scientists-warn-government-is-putting-big-bets-on-vaccines-that-may-not-work-12004889
It came out in June this year, and quotes LD saying very simply "Please give us some money. We have an exciting approach. It could be the answer."
8 weeks later in late August they got 2.7 million quid from Innovate UK, and five weeks after that entered into a collaboration with Cobra to manufacture their COVID-19 vaccine.
Given that nobody tends to hand out nearly 3 million quid without dropping by to ask what progress has been achieved with it, I wonder whether we can expect more funding relatively soon for the Covid work, over and above the Redmile/Vulpes cash in the bank. Just pondering...

Slow and steady, but building, building....that's Scancell.
Imo...

Up to 672 followers on twitter now, so a slow but steady increase in interest. Doesn't seem that long since it was in the low 200s. See what happens - it's always an interesting barometer.

That's one way if imo less likely. What other ways might be possible?

Obviously we know David Evans is now setting up the above investment company, and is putting 1 million pounds of his own money into it. Given that he is enthusiastic about Scancell and personally bought one million extra shares a while ago at 7p, the question is this - If he wants to invest in Scancell with his IIG steup, where will he source the shares? Would he persuade SCLP to issue new ones to his fund (very unlikely IMO), or would the fund have to buy on the open market? Either way, assuming of course that he did want to put fund money into Scancell, it could have a useful effect on the SP and the profile of the company too.
Just a thought for a Sunday afternoon.

Means going without meat and two veg, so to speak. Losing the family jewels. A noble life. (Sorry - should read no ball). Hope that helps.

Interesting retweet by sclp highlighting a PhD at Birmingham Uni - mentions skin and lung-focused delivery of covid and similar vaccines, and covidity described as 'funded by Innovate-UK.' More cash to come...?

Project title: Development of an intradermal or inhaled DNA vaccine for COVID-19 and beyond
Supervisors: James Dixon (University of Nottingham) with Scancell
Intradermal and inhaled delivery of nucleic acid vaccines could be clinically effective, safe and globally-deployable against multiple complex diseases. This project will aim to combine physical and peptide-based delivery systems to enhance the efficacy and application of such technologies to the COVID-19 vaccine (‘Covidity’) presently under-development by our consortium (funded by Innovate-UK). This PhD will formulate and test combined systems for skin and lung-focused vaccine delivery in ex vivo tissue models, then move to rodent models, examining virus neutralisation, T cell responses and protection in virally challenged animals. The platform technology optimised and demonstrated will have wide ranging impact on future applications of nucleic acid vaccine approaches (including DNA, mRNA and oligo-based methods). The PhD will also directly aid attempts to translate antibody and peptide-engineering knowhow to generate a rapidly deployable and safe immunisation system for multiple complex diseases.

I thought it was just a slipped timescale....

I like the last line - 'it is possible to recognise the scale of the opportunity Redmile is seeking to capture.'

Comment on him by a third party from LinkedIn- 'Gillies is a highly experienced and authoritative pharmaceutical physician. He has considerable knowledge of clinical development and is able to operate competently and persuasively at a senior level. He uses his experience and knowledge judiciously to guide clients and to preempt/resolve complex development issues.'

This man has a most impressive CV - medical and business skills in all sizes of pharma. Must have been something special about Scancell that drew him in imo.

k not m I suspect C7!

I noted it as 2.7 million in total, 2 million to Scancell and 700 thousand to Nottingham Uni.

According to the RNS, tomorrow's meeting is at 2pm so I can have a lie-in. I wonder if 2pm has been chosen so that Redmile can watch proceedings in real time without having to get up in the middle of the night?

Judging by patterns over recent times, LSE chat will collapse until about 4.30pm. But I hope not...

From your post Knowlesi - 'share price will be closer to 4p than 40p. Fact it is.'
Were you by any chance in Star Wars? That was a fantasy as well.
As for the rest of your post, the allegation of 'Spin twist and lie' is there, but only if you look in the mirror - judging by your spectacularly delusional posting today.

Hi Cars - without checking back for the exact wording I remember it as coming in around 17 percent and there was the comment that further support (as part of a long-term investment) was planned or available, and a top figure of 25 percent came up - whether that was a plan or a maximum I forget, but a certainly within the parameters of Vulpes' investment criteria. So yes, further buying by them in the open market could well be possible, but yesterday's RNS is a good message even if that's all they do.

A lot of articles (as has been said before) are a result of a press release to a journalist or agency, rather than any particular investigative work by a journalist, so will feature whatever the releaser puts in it. The Sky feature for Scancell was imo due to some determined pushing, and I'm wondering if it was part of an effort that helped lead Redmile to us. Who knows? Lack of media attention is occasionally frustrating, but behind the scenes activity is what will get real results.

Brilliant comment Quoth! Does depend on whether it's a buy or a sell for sure!

So said Knowlesi the self-confessed doom monger who clings carefully to his 'substantial holding.'
Fna'ar fna'ar.

I've only gone and got the wrong evening haven't I? I thought tonight was the the night for the secret club's midnight naked hilltop gathering, and then realised it's Thursdays, not Wednesdays. Otherwise I'd have been in bed ages ago. Till tomorrow...